TRxADE HEALTH agrees to sell Alliance Pharma and CSP to Wood Sage for up to $491k

Scienture Holdings, Inc.

Sell 100% of Alliance Pharma Solutions for $125,000 and Community Specialty Pharmacy for $100,000, plus ~$266,000 under Master Service Agreement.
Closing expected April 30, 2023, subject to Wood Sage obtaining sufficient financing.
Divestiture of unprofitable B2C operations; company to focus on B2B marketplace.
Sale follows evaluation of strategic alternatives begun in Q3 2022.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Scienture Holdings, Inc. entered into Membership Interest Purchase Agreements (Alliance Sale Agreement and CSP Sale Agreement) with Wood Sage, LLC valued at Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste (effective 2023-01-20).

Action: entry
Agreement: asset purchase
Counterparty: Wood Sage, LLC
Value: Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste
Effective: 2023-01-20

Exact text from the filing

On January 20, 2023, TRxADE HEALTH, Inc. (the “ Company ”, “ we ”, or “ us ”), entered into: (1) a Membership Interest Purchase Agreement with Wood Sage, LLC (“ Wood Sage ”), and the Company’s wholly-owned subsidiary, Alliance Pharma Solutions, LLC (“ Alliance ” and the “ Alliance Sale Agreement ”); and (2) a Membership Interest Purchase Agreement with Wood Sage and the Company’s wholly-owned subsidiary, Community Specialty Pharmacy, LLC (“ CSP ” and the “ CSP Sale Agreement ”, and together with the Alliance Sale Agreement, the “ Sale Agreements ”).

View on SEC.gov

283 material agreements filed in the last 30 days. Browse all material agreements →

Scienture Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-002126

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.